Chai Discovery
Engineering better molecules using AI
About Chai Discovery
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Pitch deck breakdown
How Chai Discovery would pitch themselves.
Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
Problem they solve
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and,… The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Chai Discovery differentiates on engineering better molecules using ai. $0 raised — the company has resources + validation to compound this thesis.
Go-to-market strategy
Growth-stage GTM — multi-channel revenue motion (direct enterprise sales, channel partnerships, marketplace listings). Vertical specialisation + verticalised AE teams targeting enterprise + mid-market.
Chai Discovery website preview
Company facts
- Category
- SaaS
- Funding stage
- Series B
- Total raised
- $0
- Founded
- 2020
- Team size
- 1–10
- HQ
- San Francisco, United States
- Country
- United States
- Website
- chaidiscovery.com
Frequently asked questions
What does Chai Discovery do?
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Where is Chai Discovery based?
Chai Discovery is based in San Francisco, United States, United States.
When was Chai Discovery founded?
Chai Discovery was founded in 2020.
How much has Chai Discovery raised?
Chai Discovery has raised $0 in their Series B round.
